Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCNU-TMZ Combination in Newly Diagnosed Anaplastic Oligodendrocytic Tumors
NCT04755023Phase 2Completed
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Dec 2005
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carmustine, temozolomide in Oligodendroglioma (OG), oligoastrocytoma, sponsored by Assistance Publique-Hôpitaux de Marseille. Started Dec 2005; status: completed.
02
Drugs
carmustinetemozolomide
03
Conditions
Oligodendroglioma (OG)oligoastrocytoma
Beyond the preview
Go deeper on NCT04755023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04755023.